Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis

Journal of Nephrology

Volumn 29, Issue 2, 2016, Pages 211-219

  Cheungpasitporn, Wisit ^a   Rossetti, Sandro ^b   Friend, Keith ^b   Erickson, Stephen B ^a   Lieske, John C ^a  

^a MAYO CLINIC   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Fluid intake; Hyponatremia; Kidney stones; Meta analysis; Water

Indexed keywords

ARTICLE; DISEASE ASSESSMENT; FLUID INTAKE; HUMAN; HYPONATREMIA; INCIDENCE; META ANALYSIS; NEPHROLITHIASIS; PATIENT COMPLIANCE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT WITHDRAWAL; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; DRINKING; FEMALE; FLUID THERAPY; KIDNEY CALCULI; MALE; MICTURITION; ODDS RATIO; PATHOPHYSIOLOGY; PROCEDURES; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; DRINKING; FEMALE; FLUID THERAPY; HUMANS; INCIDENCE; KIDNEY CALCULI; MALE; ODDS RATIO; PATIENT COMPLIANCE; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; URINATION;

EID: 84961247651     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-015-0210-4     Document Type: Article

References (31)

1. Goldfarb DS (2003) Increasing prevalence of kidney stones in the united states. Kidney Int 63:1951–1952
2. Long LO, Park S (2007) Update on nephrolithiasis management. Minerva Urol Nefrol 59:317–325
3. Lopez M, Hoppe B (2010) History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol 25:49–59
4. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the united states: 1976–1994. Kidney Int 63:1817–1823
5. Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD (2014) Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the american college of physicians. Ann Intern Med 161:659–667
6. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324
7. Wang CJ, Grantham JJ, Wetmore JB (2013) The medicinal use of water in renal disease. Kidney Int 84:45–53
8. Dawson CH, Tomson CR (2012) Kidney stone disease: pathophysiology, investigation and medical treatment. Clin Med 12:467–471
9. Bao Y, Wei Q (2012) Water for preventing urinary stones. Cochrane Database Syst Rev 6:CD004292
10. Linder BJ, Rangel LJ, Krambeck AE (2013) The effect of work location on urolithiasis in health care professionals. Urolithiasis 41:327–331
11. Sarica K, Inal Y, Erturhan S, Yagci F (2006) The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res 34:184–189
12. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843
13. Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8:1568–1573
14. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126:497–504
15. Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P (2005) Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 67:1934–1943
16. Hosking DH, Erickson SB, Van den Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130:1115–1118
17. Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15:3225–3232
18. Strauss AL, Coe FL, Deutsch L, Parks JH (1982) Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med 72:17–24
19. Embon OM, Rose GA, Rosenbaum T (1990) Chronic dehydration stone disease. Br J Urol 66:357–362
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
21. Stang A (2010) Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
24. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR (1991) Publication bias in clinical research. Lancet 337:867–872
25. Curhan GC, Willett WC, Knight EL, Stampfer MJ (2004) Dietary factors and the risk of incident kidney stones in younger women: nurses’ health study ii. Arch Intern Med 164:885–891
26. Buckley CM, Hawthorne A, Colyer A, Stevenson AE (2011) Effect of dietary water intake on urinary output, specific gravity and relative supersaturation for calcium oxalate and struvite in the cat. Br J Nutr 106(Suppl 1):S128–S130
27. Chung BD, Parekh U, Sellin JH (1999) Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol 28:29–32
28. Xu H, Zisman AL, Coe FL, Worcester EM (2013) Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother 14:435–447
29. Sawyer MD, Anderson CB, Viprakasit DP, Dietrich MS, Herrell SD, Miller NL (2013) An individualized weight-based goal urine volume model significantly improves expected calcium concentrations relative to a 2-l goal urine volume. Urolithiasis 41:403–409
30. Hariprasad MK, Eisinger RP, Nadler IM, Padmanabhan CS, Nidus BD (1980) Hyponatremia in psychogenic polydipsia. Arch Intern Med 140:1639–1642
31. Kawai N, Baba A, Suzuki T, Shiraishi H (2001) Roles of arginine vasopressin and atrial natriuretic peptide in polydipsia-hyponatremia of schizophrenic patients. Psychiatry Res 101:39–45